Lymphatics
- 3E0W3 - Percutaneous
- 3E0W30
- 3E0W305 - Introduction Lymphatics to Other Antineoplastic with Antineoplastic, Percutaneous Approach
- 3E0W30M - Introduction Lymphatics to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
- 3E0W32
- 3E0W328 - Introduction Lymphatics to Oxazolidinones with Anti-infective, Percutaneous Approach
- 3E0W329 - Introduction Lymphatics to Other Anti-infective with Anti-infective, Percutaneous Approach
- 3E0W33
- 3E0W33Z - Introduction Lymphatics to No Qualifier with Anti-inflammatory, Percutaneous Approach
- 3E0W36
- 3E0W36Z - Introduction Lymphatics to No Qualifier with Nutritional Substance, Percutaneous Approach
- 3E0W37
- 3E0W37Z - Introduction Lymphatics to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
- 3E0W3B
- 3E0W3BZ - Introduction Lymphatics to No Qualifier with Anesthetic Agent, Percutaneous Approach
- 3E0W3G
- 3E0W3GC - Introduction Lymphatics to Other Substance with Other Therapeutic Substance, Percutaneous Approach
- 3E0W3H
- 3E0W3HZ - Introduction Lymphatics to No Qualifier with Radioactive Substance, Percutaneous Approach
- 3E0W3K
- 3E0W3KZ - Introduction Lymphatics to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
- 3E0W3N
- 3E0W3NZ - Introduction Lymphatics to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
- 3E0W3T
- 3E0W3TZ - Introduction Lymphatics to No Qualifier with Destructive Agent, Percutaneous Approach
